Charlotte's Web Holdings Earnings Call Transcripts
Fiscal Year 2026
-
The meeting approved all resolutions, including director elections and a major investment by British American Tobacco, which will own about 40% of shares and nominate a second board member. Management highlighted the early-stage Medicare pilot program as a significant future growth opportunity.
Fiscal Year 2025
-
Q4 2025 saw a return to revenue growth, major cost reductions, and a transformative BAT transaction that eliminated $65M in liabilities and added $10M in capital. Positioned for growth via Medicare pilots and regulatory momentum, with strong operational and financial improvements.
-
Q2 saw 4.2% year-over-year revenue growth, margin improvement, and a 43% reduction in net loss. Cost savings and in-house manufacturing are expected to drive positive cash flow by 2026, with new product launches and omnichannel expansion fueling momentum.
Fiscal Year 2024
-
Consecutive quarterly revenue growth was achieved in 2024, with strong e-commerce and new product launches offsetting retail headwinds from state regulations. Cost reductions and operational efficiencies led to improved margins and a positive Q4 adjusted EBITDA, positioning the company for year-over-year growth and margin expansion in 2025.
-
Q2 revenue declined year-over-year but rose sequentially, with B2B and D2C segments showing improvement. Significant cost reductions and a new e-commerce platform position the business for future growth, while early Walmart sales and new product launches offer expansion opportunities.